Tome unveiled at the end of last year with a whopping $213 million in a combined series A and B round. The biotech, with ...

Borealis Biosciences, which emerged from stealth today armed with $150 million in series A funds, has been created around a ...

Eli Lilly has expanded its partnership with Oblique Therapeutics, adding a second strand to an alliance focused on using the ...

Mechanical ventilation, the use of a machine to help a person breathe, was not something many people thought about all that ...

Roche says it's actively working with its partners to enhance mpox laboratory capacity worldwide to develop diagnostic tests ...

Cancer diagnostics startup PreciseDx picked up  $20.7 million in series B funding as it ramps up commercialization efforts ...

BioAge Labs has appointed former GSK CEO Jean-Pierre Garnier as chair of its board of directors, bringing the pharma veteran ...

Johnson & Johnson said on Tuesday it will buy heart failure implant company V-Wave in a deal worth a potential $1.7 billion.

BridgeBio Pharma is once again spinning out a chunk of its pipeline, this time offloading a handful of early-stage genetic ...

With just weeks to go before the FDA decides whether to approve the first treatment for a rare genetic condition, Rafael ...

PitchBook’s report —which focuses on valuations in Europe broadly and not just in the life sciences sphere—highlights three ...

BioMarin Pharmaceutical is shaking up its leadership team, raiding Amgen for an R&D chief to replace a departing company ...